asphyxia neonatorum: Respiratory failure in the newborn. (Dorland, 27th ed)
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
202 |
4. Check minimum number of eventsNone |
202 |
5. Include endpointsNone |
202 |
6. Filter based on genotype QC (FinnGen only) |
202 |
Control definitions (FinnGen only)
- Control exclude
- P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P2
- Name in latin
- Asphyxia intra partum
Similar endpoints
↥List of similar endpoints to
Birth asphyxia
based on the number of shared cases.
Similar with more cases:
- Respiratory and cardiovascular disorders specific to the perinatal period
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 13251 | 5713 | 7536 |
| Only index persons | 7432 | 3138 | 4294 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.19 | 0.16 | 0.21 |
| Only index persons | 0.14 | 0.12 | 0.16 |
| Median age at first event (years) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 202 | 116 | 86 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 168
- Matched controls
- 1678
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P21.1
ICD-10 Finland
Mild and moderate birth asphyxia
+∞
119.5
100
*
P21.0
ICD-10 Finland
Severe birth asphyxia
+∞
64.9
58
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
20.2
39.1
61
46
P21.9
ICD-10 Finland
Birth asphyxia, unspecified
+∞
17.0
16
*
P24.0
ICD-10 Finland
Neonatal aspiration of meconium
+∞
11.6
11
*
P22.9
ICD-10 Finland
Respiratory distress of newborn, unspecified
+∞
10.5
10
*
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
105.7
9.5
10
*
P07.3
ICD-10 Finland
Other preterm infants
6.1
9.2
25
47
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
94.6
8.5
9
*
P91.02
ICD-10 Finland
Neonatal hypoxic-ischaemic encephalopathy, severe
+∞
8.4
8
*
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
+∞
8.4
8
*
WX930
NOMESCO Finland
Thepapeutic hypothermia
83.6
7.5
8
*
WX730
NOMESCO Finland
Conventional respirator
14.6
7.0
11
8
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
5.8
6.4
17
32
G80.3
ICD-10 Finland
Dyskinetic cerebral palsy
+∞
6.3
6
*
G82.4
ICD-10 Finland
Spastic tetraplegia
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020717) Zinc [Moles/volume] in Serum or Plasma
11
20
5.76
5.87
3.6
2.0
umol/l
13.9
12.1
0.64
11
20
(3022670) pH of Venous cord blood
7
9
8.01
3.58
1.0
1.0
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
8
13
6.36
3.53
3.6
2.1
umol/l
1.0
1.1
—
8
13
(3015377) Calcium [Moles/volume] in Serum or Plasma
53
338
1.77
2.99
3.5
2.6
mmol/l
2.4
2.4
0.01
46
306
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
22
4.23
2.92
1.1
1.0
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
6
9
6.83
2.88
3.5
2.2
umol/l
21.9
24.9
—
6
9
(3032641) Amino acids panel - Urine
5
6
8.50
2.76
1.0
1.3
—
—
—
0
0
(4306422)
7
14
5.14
2.75
1.0
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
7
14
5.14
2.75
1.0
1.4
%
147.4
104.7
—
7
14
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
20
4.12
2.59
1.0
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
8
6.37
2.38
2.6
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
118
961
1.55
2.38
8.4
9.2
e9/l
2.4
2.3
0.41
103
822
(3013336) Amino acids [Identifier] in Serum or Plasma
7
17
4.23
2.38
1.0
2.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
30
172
1.87
2.37
4.1
3.2
%
19.0
21.7
0.77
30
163
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
16
72
2.33
2.34
1.9
2.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
6
13
4.72
2.29
1.0
1.3
%
97.0
84.4
—
6
13
(3022948) Iron [Moles/volume] in Serum or Plasma
34
207
1.77
2.23
3.9
3.0
umol/l
13.2
13.8
0.23
34
198
(3049233) Organic acids panel - Urine
5
9
5.66
2.22
1.6
1.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
8
25
3.29
2.12
6.9
4.3
kpa
5.0
4.9
—
8
25
(3027315) Oxygen [Partial pressure] in Blood
8
25
3.29
2.12
7.0
4.3
kpa
9.8
9.0
—
8
25
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
44
2.59
2.05
1.9
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
17
84
2.12
2.02
4.9
5.7
%
0.5
0.5
—
8
21
(1616796) Gas panel - Central venous blood
9
33
2.81
1.95
6.4
4.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
46
318
1.58
1.87
2.7
3.2
—
—
—
0
0
(3015736) pH of Urine
65
487
1.49
1.84
4.3
3.1
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
5
12
4.24
1.83
1.2
1.2
umol/l
94.4
98.5
—
5
12
(3045462) Protein/Creatinine [Ratio] in Urine
10
41
2.51
1.78
15.1
7.7
g/mol
227.6
102.1
—
10
34
(3017181) Myelocytes/100 leukocytes in Blood
17
89
1.99
1.76
5.5
7.2
%
0.9
0.5
—
9
32
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
18
3.40
1.76
1.2
1.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
16
82
2.03
1.75
5.7
7.5
%
0.0
0.0
—
8
25
(3044640) Blood type and Crossmatch panel - Blood
52
377
1.51
1.71
2.8
3.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
48
342
1.53
1.71
25.4
8.7
mmol/l
0.6
1.1
0.39
39
239
(4035726)
13
63
2.14
1.63
1.5
1.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
113
956
1.41
1.63
9.5
10.0
e9/l
0.2
0.2
0.02
100
816
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
14
3.63
1.62
2.6
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
14
3.63
1.62
1.0
1.7
—
—
—
0
0
(4268621)
5
14
3.63
1.62
2.4
2.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
30
194
1.64
1.60
2.5
2.2
ng/l
17.5
15.6
—
10
60
(3051611) Lipemic interference index of Serum or Plasma
7
26
2.75
1.59
6.1
4.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
32
211
1.61
1.58
3.6
2.6
nmol/l
260.7
359.0
2.72
32
201
(3011397) Hemoglobin [Presence] in Urine by Test strip
47
339
1.50
1.58
4.0
3.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
76
602
1.42
1.58
6.7
4.6
estimate
0.0
0.0
0.00
16
118
(3013650) Neutrophils [#/volume] in Blood by Automated count
118
1009
1.41
1.58
10.1
10.9
e9/l
3.2
3.5
1.05
103
847
(3022313) Gas panel - Capillary blood
43
305
1.52
1.56
25.0
8.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
13
65
2.07
1.52
1.4
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
105
885
1.39
1.50
5.9
3.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
76
608
1.40
1.48
4.7
3.3
estimate
0.0
0.0
0.00
16
116
(3021960) Folate [Moles/volume] in Serum or Plasma
28
182
1.63
1.47
1.3
1.3
nmol/l
25.7
19.0
0.97
22
159
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
59
2.10
1.47
1.9
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
74
1.96
1.43
1.3
1.4
miu/ml
308.1
269.6
—
8
31
(3014007) Fractional oxyhemoglobin in Arterial blood
13
67
2.00
1.42
16.5
19.8
%
91.5
96.0
0.51
13
67
(3035350) Ketones [Presence] in Urine by Test strip
75
603
1.39
1.41
4.8
3.3
estimate
0.0
0.0
0.00
15
112
(3048929) Epstein Barr virus Ab [Presence] in Serum
15
256
0.55
1.40
2.6
1.7
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
29
2.46
1.40
3.1
4.0
umol/l
21.9
25.2
—
7
29
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
27
177
1.61
1.38
2.3
2.6
u/l
2883.7
6972.8
—
8
50
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
23
2.66
1.37
2.2
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
109
936
1.36
1.34
8.8
9.3
e9/l
0.6
0.5
0.14
93
780
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
43
2.14
1.32
2.1
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
36
256
1.49
1.30
2.0
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
111
959
1.35
1.29
8.4
9.3
%
36.9
35.5
0.64
104
921
(3023520) Reticulocytes [#/volume] in Blood
25
164
1.60
1.28
2.9
5.6
e9/l
74.4
66.6
0.25
16
107
(3002032) Base excess in Venous blood by calculation
45
336
1.44
1.27
8.8
11.4
mmol/l
1.1
1.1
0.05
35
264
(3021440) Promyelocytes/100 leukocytes in Blood
15
85
1.83
1.27
6.0
7.3
%
0.0
0.0
—
8
29
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
100
855
1.34
1.23
5.4
5.2
u/l
125.3
115.9
0.55
93
802
(42870588) Differential panel, method unspecified - Blood
85
711
1.34
1.21
9.1
9.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
108
936
1.33
1.20
8.9
9.3
e9/l
0.0
0.0
0.13
93
780
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
57
1.98
1.19
3.1
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
57
1.98
1.19
3.1
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
39
289
1.43
1.15
4.6
3.4
ph
7.4
7.4
—
9
53
(3001019) Free T4 and TSH panel - Serum or Plasma
7
30
2.38
1.13
1.4
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
44
335
1.40
1.12
7.5
5.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
41
1.99
1.10
1.5
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
21
2.41
1.09
3.2
2.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
131
0.52
1.03
3.4
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
63
515
1.32
1.03
1.4
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
94
812
1.29
1.02
3.6
2.5
mmol/l
2.7
2.6
0.19
94
767
(3011288) Drugs identified in Urine by Screen method
10
174
0.55
1.02
1.4
2.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
64
525
1.32
1.02
3.9
4.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
48
1.92
1.02
5.4
3.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
61
1.85
1.00
2.0
2.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
49
1.88
1.00
2.1
1.9
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
12
69
1.79
0.99
17.3
19.3
%
0.7
0.7
0.05
12
69
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
12
69
1.79
0.99
17.3
19.3
%
0.9
1.1
0.59
12
69
(3021901) Oxygen saturation in Capillary blood
7
36
1.98
0.98
13.4
9.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
36
1.98
0.98
2.4
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
17
109
1.61
0.97
4.6
3.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
81
691
1.29
0.96
23.0
11.7
mmol/l
1.2
1.2
0.41
74
639
(3024561) Albumin [Mass/volume] in Serum or Plasma
54
436
1.33
0.95
10.7
8.8
g/l
36.3
38.2
1.22
54
412
(3003181) Sodium [Moles/volume] in Urine
7
37
1.92
0.95
2.3
2.7
mmol/l
69.9
92.2
—
7
30
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
51
409
1.33
0.94
2.5
3.4
mg/l
2.8
2.7
0.25
46
367
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
93
810
1.27
0.93
3.6
2.5
mmol/l
1.4
1.4
0.22
93
770
(3020891) Body temperature
6
29
2.10
0.90
3.5
7.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
103
912
1.26
0.89
8.8
9.5
%
3.0
3.1
0.10
98
868
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
98
864
1.26
0.87
2.5
2.1
mmol/l
5.3
5.3
0.07
92
789
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
80
1.67
0.87
2.8
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
109
974
1.26
0.86
3.8
4.4
mm/h
8.0
7.3
0.26
104
902
(3000991) Gas panel - Venous blood
40
314
1.34
0.85
14.2
12.7
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
6
31
1.96
0.85
1.8
2.5
mmol/l
32.4
35.2
—
6
31
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
155
1447
1.31
0.84
9.1
8.3
u/l
31.1
24.4
0.58
149
1389
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
46
372
1.31
0.80
26.8
13.8
mmol/l
24.1
24.7
0.75
46
372
(3024471) HLA-A [Type]
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
103
922
1.24
0.78
9.0
9.5
%
8.4
8.3
0.12
98
884
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
195
0.64
0.77
1.5
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
34
1.79
0.77
1.5
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
32
247
1.35
0.77
4.6
4.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
99
885
1.23
0.75
9.0
9.7
%
0.5
0.6
1.56
92
850
(3032080) INR in Blood by Coagulation assay
38
303
1.31
0.74
3.6
3.9
inr
1.0
1.1
1.74
14
90
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
9
56
1.64
0.73
3.0
5.4
mg/l
1177.0
398.8
—
9
56
(3006245) CD3-CD19+ cells/100 cells in Blood
9
56
1.64
0.73
2.1
4.0
%
21.3
18.0
—
9
56
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
56
1.64
0.73
2.1
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
35
276
1.32
0.73
5.8
3.9
e6/l
1.6
2.4
0.46
19
161
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
167
1586
1.31
0.71
14.6
10.4
mg/l
17.9
23.2
2.00
124
1052
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
11
69
1.63
0.70
19.5
19.4
mmol/l
22.7
23.9
0.81
11
69
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
162
1696
0.77
0.70
4.3
3.9
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
7
42
1.69
0.69
3.0
2.5
g/l
131.6
134.3
—
7
35
(3042936) Bacteria identified in Isolate by Culture
21
154
1.41
0.68
1.9
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
70
1.60
0.66
2.5
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
49
411
1.25
0.65
4.5
3.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
28
218
1.33
0.64
2.5
1.6
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
5
29
1.74
0.64
1.0
1.0
g/l
161.8
162.8
—
5
29
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
38
310
1.28
0.63
1.4
1.4
pmol/l
116.7
98.1
1.15
18
170
(3029937) Albumin [Presence] in Urine by Test strip
37
301
1.28
0.63
5.2
3.4
estimate
0.0
0.0
0.00
14
112
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
30
1.68
0.62
1.4
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
30
1.68
0.62
1.4
1.1
%
92.6
74.1
—
5
30
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68
596
1.21
0.60
4.6
3.3
nmol/l
71.9
65.7
1.14
62
562
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.3
—
23.2
—
0
5
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.3
—
18.6
—
0
5
(3019225) pH of Specimen
10
64
1.59
0.59
3.9
4.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
37
305
1.26
0.57
4.9
2.9
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
6
37
1.64
0.56
2.0
1.2
—
1.9
—
0
5
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
24
187
1.32
0.56
3.2
2.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
38
1.60
0.55
2.2
2.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
60
525
1.20
0.54
8.2
8.7
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
6
39
1.55
0.53
2.0
1.7
nmol/l
0.2
0.2
—
6
32
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
39
1.55
0.53
5.0
3.9
%
47.0
49.8
—
6
39
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
42
492
0.82
0.53
2.1
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
15
109
1.41
0.52
1.1
1.4
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
13
92
1.44
0.52
6.6
4.3
nmol/l
23.2
22.7
0.05
13
92
(3016879) Cocaine [Presence] in Urine
18
234
0.75
0.52
1.4
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
96
881
1.17
0.49
6.9
6.2
ml/min/173m2
110.2
114.9
1.01
68
558
(3007461) Platelets [#/volume] in Blood
185
1799
1.34
0.49
21.0
15.0
e9/l
270.9
270.0
0.07
176
1711
(3021589) Normoblasts [#/volume] in Blood
98
903
1.17
0.47
10.2
10.8
e9/l
0.0
0.0
0.50
77
677
(3026361) Erythrocytes [#/volume] in Blood
185
1801
1.32
0.46
20.9
14.9
e12/l
4.6
4.6
0.01
177
1710
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
7
49
1.44
0.46
1.9
3.6
%
24.9
27.3
—
7
49
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
33
276
1.23
0.46
6.1
3.8
e6/l
0.8
0.9
0.09
18
161
(3028300) Cannabinoids [Presence] in Urine
20
251
0.77
0.45
1.5
1.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
50
1.41
0.45
1.0
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
55
486
1.18
0.44
8.7
4.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
20
250
0.78
0.44
1.5
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
20
250
0.78
0.44
1.5
1.7
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
7
51
1.39
0.44
2.0
3.7
%
62.0
67.1
—
7
51
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
51
1.39
0.44
2.1
3.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
51
1.39
0.44
1.4
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
185
1803
1.31
0.44
20.9
14.9
e9/l
6.9
6.8
0.41
176
1712
(3005719) IgG [Mass/volume] in Serum or Plasma
22
176
1.28
0.44
2.7
4.2
g/l
8.3
9.0
0.43
22
170
(3027944) Amphetamines [Presence] in Urine
20
249
0.78
0.43
1.5
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
45
392
1.19
0.43
4.7
4.7
u/l
31.3
31.0
0.03
45
378
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
40
345
1.20
0.42
1.8
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
58
1.39
0.42
23.5
19.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
33
1.53
0.41
2.4
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
33
1.53
0.41
1.2
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
33
1.53
0.41
2.4
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
16
0.00
0.41
0.0
3.6
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
3.8
—
0
9
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.1
—
21.9
—
0
9
(3041672) Baker's yeast Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
34
1.48
0.40
2.4
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
115
1.33
0.40
1.2
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
18
0.00
0.40
0.0
1.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
11
80
1.40
0.39
3.3
1.8
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
36
1.40
0.38
1.6
1.5
—
—
—
0
0
(4062490)
5
36
1.40
0.38
1.0
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
68
1.34
0.38
4.1
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
179
0.77
0.37
1.4
1.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
9
70
1.30
0.37
1.0
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
70
1.30
0.37
3.8
3.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
161
1555
1.17
0.37
11.8
7.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
90
1.35
0.36
1.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
43
1.41
0.35
1.8
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
25
295
0.83
0.35
2.1
2.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
20
164
1.24
0.34
2.6
3.2
ng/l
2952.6
1265.5
—
8
88
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
45
1.34
0.34
2.2
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
45
1.34
0.34
2.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
45
1.34
0.34
2.2
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
45
1.34
0.34
2.2
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
135
1292
1.14
0.33
3.8
3.6
mu/l
2.0
2.0
0.01
129
1215
(3003327) Ova and parasites identified in Stool by Light microscopy
7
98
0.70
0.31
1.1
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
61
558
1.13
0.31
10.3
4.9
e6/l
64.1
85.4
0.22
42
379
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
53
1.33
0.31
2.0
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
54
1.31
0.30
3.4
5.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
18
148
1.24
0.30
3.4
1.9
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
55
1.28
0.30
1.3
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
49
443
1.14
0.30
8.1
4.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
18
149
1.23
0.29
3.5
2.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
62
1.30
0.28
14.1
9.8
—
561.6
—
0
11
(3028707) Methadone [Presence] in Urine by Screen method
9
119
0.75
0.28
1.7
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
79
740
1.11
0.27
1.8
1.7
u/ml
1.1
2.8
0.95
14
138
(3007164) IgA [Mass/volume] in Serum or Plasma
72
671
1.11
0.27
1.4
1.7
g/l
1.8
1.6
0.44
37
341
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
16
132
1.23
0.26
1.2
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
72
0.69
0.26
1.0
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
48
438
1.13
0.26
8.2
4.2
e6/l
0.1
0.2
0.55
38
339
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
80
847
0.91
0.24
2.2
2.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
38
1.32
0.23
5.6
3.5
e9/l
3.6
3.0
—
5
38
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
38
1.32
0.23
1.6
6.6
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
39
1.29
0.23
1.4
7.2
%
103.2
89.9
—
5
39
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
91
0.76
0.23
3.6
2.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
92
0.75
0.23
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
8
103
0.77
0.21
1.1
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
173.9
—
0
11
(3045424) Erythrocytes [Presence] in Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
11
0.00
0.21
0.0
4.9
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
11
0.00
0.21
0.0
4.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(4094501)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
6.0
—
251.7
—
0
10
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
102.3
—
0
12
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
12
0.00
0.21
0.0
3.2
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
27.1
—
0
6
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
832.4
—
0
12
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.0
—
0
5
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
0.3
—
0
12
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
159
1625
0.90
0.21
18.5
13.8
%
39.7
39.4
0.30
141
1428
(3036071) Salmonella sp Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
13
0.00
0.21
0.0
3.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
108
1.22
0.20
1.2
2.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
48
1.26
0.20
1.2
2.7
—
—
—
0
0
(44790048)
6
48
1.26
0.20
1.5
2.0
—
—
—
0
0
(44806118)
6
48
1.26
0.20
1.5
2.0
—
—
—
0
0
(44790047)
6
48
1.26
0.20
1.5
2.0
—
—
—
0
0
(44790049)
6
48
1.26
0.20
1.5
2.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
50
1.21
0.20
3.7
5.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
50
465
1.10
0.19
9.4
4.4
e6/l
10.5
30.6
2.03
40
364
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
6
53
1.14
0.19
1.0
1.1
—
10.8
—
0
8
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
26
233
1.13
0.19
4.9
5.2
mg/l
2.2
2.5
0.06
19
159
(3022621) pH of Urine by Test strip
7
61
1.15
0.17
3.6
1.9
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
13
110
1.19
0.17
8.4
8.2
%
173.8
162.2
0.21
13
110
(3013512) EKG study
15
173
0.86
0.17
2.2
2.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
5
66
0.75
0.17
1.2
1.3
—
—
—
0
0
(4010399)
6
76
0.78
0.16
1.7
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
140
0.85
0.15
1.8
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
78
1.16
0.15
1.4
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
79
1.15
0.15
1.3
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7
87
0.80
0.15
3.3
2.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
33
305
1.10
0.15
1.9
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
34
315
1.10
0.14
4.5
2.8
kg/l
1.0
1.0
—
8
47
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
13
149
0.86
0.14
1.2
1.2
iu/ml
186.0
174.7
—
5
50
(36660697) Celiac disease serology panel - Serum
29
314
0.91
0.14
1.2
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
154
1564
0.94
0.12
19.2
13.9
g/l
334.9
335.0
0.03
154
1539
(3000330) Specific gravity of Urine by Test strip
5
45
1.11
0.10
1.6
2.2
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
5
46
1.09
0.09
2.0
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
5
47
1.07
0.09
1.0
1.5
g/l
0.4
0.7
—
5
39
(3024928) Oxygen saturation in Venous blood
6
54
1.11
0.09
1.0
20.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
16
146
1.10
0.08
1.3
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
62
0.80
0.08
2.0
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
65
0.76
0.08
1.2
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
7
65
1.08
0.08
3.6
2.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
16
147
1.10
0.07
1.2
1.2
u/ml
0.3
0.9
—
10
104
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
49
506
0.96
0.06
2.6
2.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
52
504
1.04
0.06
2.2
2.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
129
1.09
0.06
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
11
101
1.09
0.04
1.1
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
116
1147
1.03
0.04
3.5
3.2
pmol/l
14.3
14.4
0.17
110
1024
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
119
0.92
0.04
1.9
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
26
250
1.05
0.03
1.5
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
30
290
1.04
0.03
1.6
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
239
0.96
0.03
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
26
252
1.04
0.02
1.8
1.9
mmol/l
1.6
1.2
1.17
26
233
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
153
1.05
0.01
1.2
1.3
u/ml
0.2
2.9
2.37
11
100
(3000494) Fungus identified in Specimen by Culture
13
124
1.05
0.00
5.5
1.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
13
136
0.95
0.00
2.1
2.5
u/l
8.0
6.1
—
6
96
(3044889) 12 lead EKG panel
59
596
0.99
0.00
1.9
2.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
116
1.04
0.00
1.9
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
35
351
1.00
0.00
3.3
2.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
53
531
1.00
0.00
2.7
2.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
97
1.03
0.00
1.6
2.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
34
343
0.99
0.00
2.1
2.4
—
—
—
0
0
(3000492) Spirometry study
10
105
0.95
0.00
1.8
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
0
5
0.00
0.00
0.0
1.6
—
1.9
—
0
5
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4146454)
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
86
0.93
0.00
1.1
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
70
1.00
0.00
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
55
0.91
0.00
1.8
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
52
0.96
0.00
1.8
1.9
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
25.6
—
0
5
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
106.6
—
0
5
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
21.0
—
25.8
—
0
6
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
2120.0
—
0
5
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
20.6
—
0
5
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
6
0.00
0.00
0.0
20.8
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(4024509)
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
9
89
1.01
0.00
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.0
—
0.4
—
0
5
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
9.8
—
0
5
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
5
51
0.98
0.00
3.6
2.3
nmol/l
0.1
0.4
—
5
44
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
12
120
1.00
0.00
2.3
2.5
iu/l
18.1
8.9
—
7
78
Mortality – FinRegistry
↥Association
Association between endpoint P16_BIRTH_ASPHYXIA and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_BIRTH_ASPHYXIA | 2.191 [1.71, 2.8] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.038 |
During the follow-up period (1.1.1998 — 31.12.2019), 67 out of 6809 males with P16_BIRTH_ASPHYXIA died.
Mortality risk
Mortality risk for people of age
years, who have P16_BIRTH_ASPHYXIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.517% |
| 5 | No data | 2.843% |
| 10 | No data | 7.153% |
| 15 | No data | 12.962% |
| 20 | No data | 22.039% |
Relationships between endpoints
↥Index endpoint: P16_BIRTH_ASPHYXIA – Birth asphyxia
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data